1060802-18-7

Basic information

• Product Name: 5-chloropyridine-3-sulfonyl chloride
• Synonyms: 5-chloropyridine-3-sulfonyl chloride;Vonoprazan Impurity 22;5-Chloro-3-pyridinesulfonyl Chloride;Vonoprazan Impurity 36
• CAS NO: 1060802-18-7
• Molecular Formula: C5H3Cl2NO2S
• Molecular Weight: 212.05382
• Mol File: 1060802-18-7.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 5-chloropyridine-3-sulfonyl chloride(CAS DataBase Reference)
• NIST Chemistry Reference: 5-chloropyridine-3-sulfonyl chloride(1060802-18-7)
• EPA Substance Registry System: 5-chloropyridine-3-sulfonyl chloride(1060802-18-7)

Safety Data

• Hazardous Substances Data: 1060802-18-7(Hazardous Substances Data)

Usage

Uses

5-Chloro-3-pyridinesulfonyl Chloride is used as a reagent to prepare proton pump inhibitors such as Tetrahydrocyclopentapyrroles.

Upstream product

• 1210868-16-8 3-(benzylsulfanyl)-5-chloropyridine 
• 150145-19-0 trifluoromethanesulfonic acid 5-chloro-3-pyridinyl ester 
• 74115-12-1 5-chloropyridin-3-ol 
• 22353-34-0 5-chloropyridin-3-amine 
• 73583-39-8 3-bromo-5-chloropyridine 

Relevant articles and documents

ACLY INHIBITORS AND USES THEREOF

The present invention provides compounds useful as inhibitors of ATP citrate lyase (ACLY), compositions thereof, and methods of using the same.

SULFONYL PYRIDYL TRP INHIBITORS

The invention is concerned with the compounds of formula I: (I) and pharmaceutically acceptable salts thereof where R1 is a substituted or unsubstituted phenyl or a fused bicyclic comprising a substituted or unsubstituted phenyl. In addition, t

PYRROLE COMPOUNDS

The present invention relates to a compound represented by the formula: wherein A is pyridyl group having at least one substituent wherein R1, R2 and R3 are each a hydrogen atom, a halogen atom, a C1-6 alkyl group optionally substituted by halogen or a C1-6 alkoxy group optionally substituted by halogen, R4 and R6 are each a hydrogen atom, a halogen atom or a C1-6 alkyl group optionally substituted by halogen, R5 is a hydrogen atom, a halogen atom, a C1-6 alkyl group optionally substituted by halogen or a C1-6 alkoxy group optionally substituted by halogen, and R7 is a hydrogen atom or a C1-6 alkyl group optionally substituted by halogen or a salt thereof, or a pharmaceutical composition containing the same.